Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML, Morra E, Pangalis GA, San Miguel JF, Branagan AR, Dimopoulos MA. Clinicopathological definition of Waldenstrom’s macroglobulinemia: consensus panel recommendations from the Second international workshop on Waldenstrom’s macroglobulinemia. Semin Oncol. 2003;30(2):110–5. https://doi.org/10.1053/sonc.2003.50082.

Article  PubMed  Google Scholar 

Marinella MA, Kim MH, Anderson MM. Waldenstrom’s macroglobulinemia transformed into immunoblastic lymphoma presenting with malignant ascites. Am J Hematol. 1996;51(3):249–50. https://doi.org/10.1002/(sici)1096-8652(199603)51:3%3c249::Aid-ajh18%3e3.0.Co;2-b.

Article  CAS  PubMed  Google Scholar 

Stien S, Durot E, Durlach A, Beylot-Barry M, Adamski H, Beltraminelli H, Bohelay G, Carlotti A, Carpentier O, Cornillet P, Dubois R, Franck N, Husson B, Laroche L, Maubec E, le Clech C, Machet L, Ortonne N, Ram-Wolff C, Vergier B, Grange F. Cutaneous involvement in Waldenströms macroglobulinaemia. Acta Dermato-Venereol. 2020;100(15):00225. https://doi.org/10.2340/00015555-3535.

Article  CAS  Google Scholar 

Chubachi A, Ohtani H, Sakuyama M, Nimura T, Mamiya S, Saitoh M, Watanuki T, Miura AB. Diffuse large cell lymphoma occurring in a patient with Waldenström’s macroglobulinemia. Evidence for the two different clones in Richter’s syndrome. Cancer. 1991;68(4):781–5.

Article  CAS  PubMed  Google Scholar 

Kobayashi H, Asada N, Egusa Y, Ikeda T, Sakamoto M, Abe M, Ennishi D, Sakata M, Takaki A, Kawahara S, Meguri Y, Nishimori H, Fujii N, Matsuoka KI, Sato Y, Yoshino T, Maeda Y. Transformation to diffuse large B-cell lymphoma with germinal center B-cell like subtype and discordant light chain expression in a patient with Waldenström macroglobulinemia/lymphoplasmacytic lymphoma. Int J Hematol. 2021;114(3):401–7. https://doi.org/10.1007/s12185-021-03157-z.

Article  CAS  PubMed  Google Scholar 

Owen RG, Bynoe AG, Varghese A, de Tute RM, Rawstron AC. Heterogeneity of histological transformation events in Waldenström’s macroglobulinemia (WM) and related disorders. Clin Lymphoma Myeloma Leuk. 2011;11(1):176–9. https://doi.org/10.3816/CLML.2011.n.042.

Article  CAS  PubMed  Google Scholar 

Kline KAF, Lee ST, Law JY, Kallen M. Waldenstrom macroglobulinemia and simultaneous intravascular large B-cell lymphoma: rare transformation or unhappy coincidence? Clin Lymphoma Myeloma Leuk. 2022;22(8):e788-91. https://doi.org/10.1016/j.clml.2022.04.008.

Article  CAS  PubMed  Google Scholar 

Castillo JJ, Gustine J, Meid K, Dubeau T, Hunter ZR, Treon SP. Histological transformation to diffuse large B-cell lymphoma in patients with Waldenström macroglobulinemia. Am J Hematol. 2016;91(10):1032–5. https://doi.org/10.1002/ajh.24477.

Article  CAS  PubMed  Google Scholar 

Durot E, Tomowiak C, Michallet AS, Dupuis J, Hivert B, Leprêtre S, Toussaint E, Godet S, Merabet F, Van Den Neste E, Ivanoff S, Roussel X, Zini JM, Regny C, Lemal R, Sutton L, Perrot A, Le Dû K, Kanagaratnam L, Morel P, Leblond V, Delmer A. Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French innovative Leukemia organization (FILO). Br J Haematol. 2017;179(3):439–48. https://doi.org/10.1111/bjh.14881.

Article  CAS  PubMed  Google Scholar 

Leleu X, Soumerai J, Roccaro A, Hatjiharissi E, Hunter ZR, Manning R, Ciccarelli BT, Sacco A, Ioakimidis L, Adamia S, Moreau AS, Patterson CJ, Ghobrial IM, Treon SP. Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs. J Clin Oncol Offi J Am Soc Clin Oncol. 2009;27(2):250–5. https://doi.org/10.1200/jco.2007.15.1530.

Article  Google Scholar 

Jiménez C, Alonso-Álvarez S, Alcoceba M, Ordóñez GR, García-Álvarez M, Prieto-Conde MI, Chillón MC, Balanzategui A, Corral R, Marín LA, Gutiérrez NC, Puig N, Sarasquete ME, González M, García-Sanz R. From Waldenström’s macroglobulinemia to aggressive diffuse large B-cell lymphoma: a whole-exome analysis of abnormalities leading to transformation. Blood Cancer J. 2017;7(8):e591. https://doi.org/10.1038/bcj.2017.72.

Article  PubMed  PubMed Central  Google Scholar 

Lin P, Mansoor A, Bueso-Ramos C, Hao S, Lai R, Medeiros LJ. Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia, Clinicopathologic features of 12 cases. Am J Clin Pathol. 2003;120(2):246–53. https://doi.org/10.1309/r01v-xg46-mfcd-vnhl.

Article  PubMed  Google Scholar 

Durot E, Kanagaratnam L, Zanwar S, Toussaint E, Kastritis E, D’Sa S, Alcoceba M, Tomowiak C, Hivert B, Protin C, Abeykoon JP, Vos JMI, Michallet AS, Rodier C, Dupuis J, Leprêtre S, Merabet F, Roussel X, Zini JM, Regny C, Patel A, Morel P, Roos-Weil D, Treon SP, Dimopoulos MA, Garcia-Sanz R, Kapoor P, Castillo JJ, Delmer AJ. High frequency of central nervous system involvement in transformed Waldenström macroglobulinemia. Blood Adv. 2022;6(12):3655–8. https://doi.org/10.1182/bloodadvances.2022007331.

Article  PubMed  PubMed Central  Google Scholar 

Minnema MC, Kimby E, D’Sa S, Fornecker LM, Poulain S, Snijders TJ, Kastritis E, Kremer S, Fitsiori A, Simon L, Davi F, Lunn M, Castillo JJ, Patterson CJ, Le Garff-Tavernier M, Costopoulos M, Leblond V, Kersten MJ, Dimopoulos MA, Treon SP. Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome. Haematologica. 2017;102(1):43–51. https://doi.org/10.3324/haematol.2016.147728.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castillo JJ, Treon SP. How we manage Bing-Neel syndrome. Br J Haematol. 2019;187(3):277–85. https://doi.org/10.1111/bjh.16167.

Article  PubMed  Google Scholar 

Castillo JJ, Olszewski AJ, Kanan S, Meid K, Hunter ZR, Treon SP. Survival outcomes of secondary cancers in patients with Waldenström Macroglobulinemia: an analysis of the SEER database. Am J Hematol. 2015;90(8):696–701. https://doi.org/10.1002/ajh.24052.

Article  PubMed  Google Scholar